| scholarly article | Q13442814 |
| P2093 | author name string | Diego Restrepo | |
| Kenneth N Maclean | |||
| Fabio M Simoes de Souza | |||
| Nicolas Busquet | |||
| Megan Blatner | |||
| P2860 | cites work | The human olfactory receptor gene family | Q24312045 |
| A novel multigene family may encode odorant receptors: a molecular basis for odor recognition | Q28276183 | ||
| Olfactory dysfunction in Down's Syndrome. | Q52047307 | ||
| Effects of different doses of galanthamine, a long-acting acetylcholinesterase inhibitor, on memory in mice. | Q52111069 | ||
| Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease. | Q52125750 | ||
| Neuronal loss and beta-amyloid removal in the amygdala of people with Down syndrome. | Q52172749 | ||
| Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients. | Q53255393 | ||
| Effects of the ApoE epsilon4 allele on olfactory function in Down syndrome. | Q53366593 | ||
| The nucleus basalis magnocellularis: The origin of a cholinergic projection to the neocortex of the rat | Q58493730 | ||
| Functional expression of a mammalian odorant receptor | Q64382213 | ||
| Characterization of sensorimotor performance, reproductive and aggressive behaviors in segmental trisomic 16 (Ts65Dn) mice | Q71712838 | ||
| Olfactory impairment increases as a function of age in persons with Down syndrome | Q77384399 | ||
| Cognitive deficits in Down syndrome: narrowing ‘Down’ to Olig1 and Olig2 | Q82204379 | ||
| Short-term memory and vocabulary development in children with Down syndrome and children with specific language impairment | Q43832909 | ||
| Galanthamine, an acetylcholinesterase inhibitor: a time course of the effects on performance and neurochemical parameters in mice | Q46045470 | ||
| Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome | Q46787034 | ||
| Mechanisms of action of acetylcholine in the guinea-pig cerebral cortex in vitro | Q46971564 | ||
| Brain disorders: getting 'Down' to the gene | Q48111342 | ||
| Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases | Q48617670 | ||
| Spontaneous stereotypy in an animal model of Down syndrome: Ts65Dn mice | Q48705924 | ||
| Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome | Q48718482 | ||
| Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease | Q48801795 | ||
| Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function | Q49061146 | ||
| Discrimination of "odorless" mineral oils alone and as diluents by behaviorally trained mice. | Q51930262 | ||
| Operant conditioning in the Ts65Dn mouse: learning. | Q52003090 | ||
| A mouse model for Down syndrome exhibits learning and behaviour deficits. | Q52013436 | ||
| Motor dysfunction in a mouse model for Down syndrome. | Q52029981 | ||
| Olfactory identification deficits in Down's syndrome and idiopathic mental retardation. | Q52033858 | ||
| Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome | Q28288207 | ||
| Chromosome 21 and down syndrome: from genomics to pathophysiology | Q28290257 | ||
| Olfactory discrimination varies in mice with different levels of α7-nicotinic acetylcholine receptor expression | Q30473395 | ||
| Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1). | Q30477664 | ||
| Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice. | Q31104439 | ||
| Loss of olfactory function in dementing disease | Q33640179 | ||
| Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice. | Q34156343 | ||
| Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer's disease | Q34169501 | ||
| Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome | Q34176485 | ||
| Down's syndrome | Q34191091 | ||
| Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome | Q34204889 | ||
| Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain | Q34714755 | ||
| Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. | Q34918986 | ||
| Understanding mental retardation in Down's syndrome using trisomy 16 mouse models | Q35204307 | ||
| Activity, modulation and role of basal forebrain cholinergic neurons innervating the cerebral cortex | Q35598409 | ||
| Acetylcholine and olfactory perceptual learning | Q35640761 | ||
| On dendrites in Down syndrome and DS murine models: a spiny way to learn. | Q35935186 | ||
| Scent wars: the chemobiology of competitive signalling in mice | Q35954449 | ||
| Mouse models of cognitive disorders in trisomy 21: a review | Q36416234 | ||
| Olfactory deficit detected by fMRI in early Alzheimer's disease | Q36449520 | ||
| The mouse olfactory receptor gene family | Q36605181 | ||
| Olfactory function in young adolescents with Down's syndrome | Q36898051 | ||
| Down syndrome: from understanding the neurobiology to therapy | Q37347649 | ||
| Simple behavioral assessment of mouse olfaction | Q37365567 | ||
| Odor perception and olfactory bulb plasticity in adult mammals | Q37406554 | ||
| In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model. | Q37407381 | ||
| Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome | Q37680415 | ||
| Ts65Dn -- localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome | Q38492220 | ||
| Odor-guided behavior in mammals | Q39730070 | ||
| Discrimination of saturated aldehydes by the rat I7 olfactory receptor. | Q41826281 | ||
| Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory | Q42435702 | ||
| Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome | Q42437959 | ||
| Multiple and opposing roles of cholinergic transmission in the main olfactory bulb. | Q42479076 | ||
| Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome | Q42483994 | ||
| The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat. | Q42486512 | ||
| Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: altered behavior in the elevated plus maze and open field | Q42640762 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported | Q15643954 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 137 | |
| P577 | publication date | 2011-11-02 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome | |
| P478 | volume | 1 |
| Q92327129 | Alzheimer's Disease Pharmacotherapy in Relation to Cholinergic System Involvement |
| Q26766934 | Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders |
| Q93140402 | Cholinesterase inhibitors as Alzheimer's therapeutics (Review) |
| Q38865366 | Dementia in Down's syndrome |
| Q34378145 | Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial. |
| Q36637693 | Hypocellularity in the Murine Model for Down Syndrome Ts65Dn Is Not Affected by Adult Neurogenesis |
| Q30422188 | Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations |
| Q22252566 | Prospects for Improving Brain Function in Individuals with Down Syndrome |
| Q46193918 | Rodent models in Down syndrome research: impact and future opportunities. |
| Q26779297 | Timing of therapies for Down syndrome: the sooner, the better |
Search more.